Hampshire PCT said the National Institute for Health and Clinical Excellence (Nice) currently recommends that Sunitinib is not used for the treatment of advanced and metastatic renal cell carcinoma (kidney cancer).

BBC: Woman in postcode drugs lottery

On the FDA's Fast Track and in phase III testing is the company's BAY 43-9006, a small molecule RAF kinase and VEGF inhibitor that inhibits tumor growth for patients with metastatic renal cell carcinoma (advanced kidney cancer).

FORBES: Beware Of Biotechs At Cancer-Cure Prices